BNP PARIBAS FINANCIAL MARKETS - OVID THERAPEUTICS INC ownership

OVID THERAPEUTICS INC's ticker is OVID and the CUSIP is 690469101. A total of 63 filers reported holding OVID THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of OVID THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$33,216
-34.7%
8,650
-44.2%
0.00%
Q2 2023$50,856
+1695100.0%
15,505
+1550400.0%
0.00%
Q1 2023$3
+50.0%
10.0%0.00%
Q4 2022$2
-100.0%
1
-99.4%
0.00%
Q3 2022$293,000
-87.3%
159
-85.2%
0.00%
Q2 2022$2,307,000
+1065.2%
1,073
+1603.2%
0.00%
Q1 2022$198,000
-2.0%
630.0%0.00%
Q4 2021$202,000
-4.7%
630.0%0.00%
Q3 2021$212,000
-98.4%
63
-98.2%
0.00%
Q2 2021$13,427,000
-43.1%
3,434
-41.5%
0.00%
Q1 2021$23,613,000
-64.4%
5,874
-34.1%
0.00%
Q4 2020$66,329,000
+18.4%
8,914
-8.7%
0.00%
Q3 2020$56,034,000
+374.0%
9,762
+508.6%
0.00%
Q2 2020$11,821,000
+5556.0%
1,604
+2191.4%
0.00%
Q1 2020$209,000
-27.9%
700.0%0.00%
Q4 2019$290,000
-94.2%
70
-95.5%
0.00%
Q3 2019$5,025,000
+75.1%
1,5510.0%0.00%
Q2 2019$2,869,000
-42.1%
1,551
-44.6%
0.00%
Q1 2019$4,954,000
+718.8%
2,799
+1019.6%
0.00%
Q4 2018$605,000
-74.7%
250
-40.8%
0.00%
Q3 2018$2,393,000
-27.3%
4220.0%0.00%
Q2 2018$3,292,000
-79.8%
422
-81.7%
0.00%
Q1 2018$16,303,000
+58.4%
2,306
+121.1%
0.00%
Q4 2017$10,294,000
+143.6%
1,043
+111.6%
0.00%
Q3 2017$4,225,000
-24.0%
493
-7.0%
0.00%
Q2 2017$5,560,0005300.00%
Other shareholders
OVID THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
AWH Capital, L.P. 230,000$407,0000.69%
BVF INC/IL 3,293,000$5,829,0000.65%
COWEN INC. 1,101,414$1,950,0000.21%
ARMISTICE CAPITAL, LLC 1,780,000$3,151,0000.17%
Granite Point Capital Management, L.P. 417,857$740,0000.07%
Redmile Group, LLC 737,550$1,305,0000.04%
Tekla Capital Management LLC 496,977$880,0000.04%
Fairpointe Capital LLC 101,000$179,0000.01%
Alyeska Investment Group, L.P. 225,000$398,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 84,440$149,0000.00%
View complete list of OVID THERAPEUTICS INC shareholders